166 related articles for article (PubMed ID: 25117863)
1. Chronic renal disease and risk of cardiovascular morbidity-mortality.
Santoro A; Mandreoli M
Kidney Blood Press Res; 2014; 39(2-3):142-6. PubMed ID: 25117863
[TBL] [Abstract][Full Text] [Related]
2. Do patients with chronic kidney disease get optimal cardiovascular risk reduction?
Elliott MK; McCaughan JA; Fogarty DG
Curr Opin Nephrol Hypertens; 2014 May; 23(3):267-74. PubMed ID: 24694581
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular disease in chronic kidney disease: risk factors, pathogenesis, and prevention.
Ardhanari S; Alpert MA; Aggarwal K
Adv Perit Dial; 2014; 30():40-53. PubMed ID: 25338421
[TBL] [Abstract][Full Text] [Related]
4. Sex differences in hypertension-related renal and cardiovascular diseases in Italy: the I-DEMAND study.
Muiesan ML; Ambrosioni E; Costa FV; Leonetti G; Pessina AC; Salvetti M; Trimarco B; Volpe M; Pontremoli R; Deferrari G; Rosei EA
J Hypertens; 2012 Dec; 30(12):2378-86. PubMed ID: 23137952
[TBL] [Abstract][Full Text] [Related]
5. The association between chronic kidney disease and cardiovascular disease risk factors in atomic bomb survivors.
Sera N; Hida A; Imaizumi M; Nakashima E; Akahoshi M
Radiat Res; 2013 Jan; 179(1):46-52. PubMed ID: 23148507
[TBL] [Abstract][Full Text] [Related]
6. Of heart and kidney: a complicated love story.
Gaita D; Mihaescu A; Schiller A
Eur J Prev Cardiol; 2014 Jul; 21(7):840-6. PubMed ID: 23012690
[TBL] [Abstract][Full Text] [Related]
7. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
8. [Risk factors for cardiovascular system damage in chronic kidney disease].
Kutyrina IM; Rudenko TE; Savel'eva SA; Shvetsov MIu; Vasil'eva MP
Ter Arkh; 2013; 85(9):69-76. PubMed ID: 24261233
[TBL] [Abstract][Full Text] [Related]
9. Socio-economic disparities in the distribution of cardiovascular risk in chronic kidney disease stage 3.
Fraser SD; Roderick PJ; McIntyre NJ; Harris S; McIntyre CW; Fluck RJ; Taal MW
Nephron Clin Pract; 2012; 122(1-2):58-65. PubMed ID: 23548499
[TBL] [Abstract][Full Text] [Related]
10. Cardiorenal syndrome type 4: management.
Clementi A; Virzì GM; Brocca A; de Cal M; Vescovo G; Granata A; Ronco C
Blood Purif; 2013; 36(3-4):200-9. PubMed ID: 24496191
[TBL] [Abstract][Full Text] [Related]
11. Strategy to estimate risk progression of chronic kidney disease, cardiovascular risk, and referral to nephrology: the EPIRCE Study.
Gayoso-Diz P; Otero-González A; Rodríguez-Álvarez MX; García F; González-Quintela A; Martin de Francisco AL
Nefrologia; 2013; 33(2):223-30. PubMed ID: 23511758
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
Brantsma AH; Bakker SJ; Hillege HL; de Zeeuw D; de Jong PE; Gansevoort RT;
Nephrol Dial Transplant; 2008 Dec; 23(12):3851-8. PubMed ID: 18641082
[TBL] [Abstract][Full Text] [Related]
13. Cross-sectional survey of the prevalence of reduced estimated glomerular filtration rate, albuminuria and cardiovascular risk in a native Spanish population.
Robles NR; Felix FJ; Fernandez-Berges D; Perez-Castán JF; Zaro MJ; Lozano L; Alvarez-Palacios P; Garcia-Trigo A; Tejero V; Morcillo Y; Hidalgo AB
J Nephrol; 2013; 26(4):675-82. PubMed ID: 23100180
[TBL] [Abstract][Full Text] [Related]
14. Risk stratification of cardiovascular events in patients at all stages of chronic kidney disease using myocardial perfusion SPECT.
Yoda S; Nakanishi K; Tano A; Kasamaki Y; Kunimoto S; Matsumoto N; Sato Y; Hirayama A
J Cardiol; 2012 Nov; 60(5):377-82. PubMed ID: 22890072
[TBL] [Abstract][Full Text] [Related]
15. Association of clustering of major cardiovascular risk factors with chronic kidney disease in the adult population.
Kong X; Ma X; Cui M; Xu D
Clin Nephrol; 2014 Aug; 82(2):92-7. PubMed ID: 24887299
[TBL] [Abstract][Full Text] [Related]
16. Is lipid management effective for all stages of CKD?
Ku E; Campese V
Blood Purif; 2013; 35(1-3):26-30. PubMed ID: 23343543
[TBL] [Abstract][Full Text] [Related]
17. Use of Chronic Kidney Disease to Enhance Prediction of Cardiovascular Risk in Those at Medium Risk.
Chia YC; Lim HM; Ching SM
PLoS One; 2015; 10(10):e0141344. PubMed ID: 26496190
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary hypertension: epidemiology in different CKD stages and its association with cardiovascular morbidity.
Li Z; Liang X; Liu S; Ye Z; Chen Y; Wang W; Li R; Xu L; Feng Z; Shi W
PLoS One; 2014; 9(12):e114392. PubMed ID: 25525807
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular disease in chronic kidney disease.
Saran AM; DuBose TD
Ther Adv Cardiovasc Dis; 2008 Dec; 2(6):425-34. PubMed ID: 19124439
[TBL] [Abstract][Full Text] [Related]
20. The Modification of Diet in Renal Disease 4-calculated glomerular filtration rate is a better prognostic factor of cardiovascular events than classical cardiovascular risk factors in patients with peripheral arterial disease.
Romero JM; Bover J; Fite J; Bellmunt S; Dilmé JF; Camacho M; Vila L; Escudero JR
J Vasc Surg; 2012 Nov; 56(5):1324-30. PubMed ID: 22795519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
